Federal grants to Mitotherapeutix, LLC
Mitotherapeutix, LLC in Woodbridge, Connecticut received $2.3 million in federal grants from fiscal 2021 to 2025, across 2 awards. Its largest program was Diabetes, Digestive, and Kidney Diseases Extramural Research, with $2.1 million. In fiscal 2025 more was taken back from its awards than added, a net -$69,103.
From USAspending.gov award records, updated October 31, 2026.
- Grants, FY 2021 to 2025$2.3 million
- Awards2
- Awarded in FY 2025-$69,103
- Largest award$2.1 million
By year
| Fiscal year | Awards | Amount |
|---|---|---|
| FY 2021 | 1 | $253,050 |
| FY 2022 | 1 | $860,261 |
| FY 2023 | 2 | $1.3 million |
| FY 2024 | 0 | $0 |
| FY 2025 | 0 | -$69,103 |
Programs that fund Mitotherapeutix, LLC
| Program | Awards | Amount |
|---|---|---|
| Diabetes, Digestive, and Kidney Diseases Extramural Research | 1 | $2.1 million |
| Alcohol Research Programs | 1 | $273,918 |
Awarding agencies
| Agency | Awards | Amount |
|---|---|---|
| Department of Health and Human Services | 2 | $2.4 million |
Largest awards
| Award | Program | First action | Amount |
|---|---|---|---|
| A novel approach to treat non-alcoholic steatohepatitis (NASH) - abstract the goal of this sbir fast-track application is to carry out a number of ind enabling studies on our sirna drug candidate, which is designed to treat non-alcohol steatohepatitis (NASH). Nash is a form of non-alcohol fatty live | Diabetes, Digestive, and Kidney Diseases Extramural Research | May 26, 2021 | $2.1 million |
| Novel treatment for alcohol-associated liver disease - abstract the specific aim of this phase i ttr proposal is to test the feasibility of our sirna drug to ameliorate the pathology and progression of alcohol-associated liver disease (ALD). Alcohol consumption remains a leading cause of hepatic pat | Alcohol Research Programs | March 15, 2023 | $273,918 |
Questions people ask
How much federal grant money does Mitotherapeutix, LLC get?
$2.3 million in 2 grant awards from fiscal 2021 to 2025, as obligations reported to USAspending.gov.
Which agency gives Mitotherapeutix, LLC the most?
The Department of Health and Human Services, with $2.4 million in 2 awards.
What is Mitotherapeutix, LLC's largest federal grant?
$2.1 million under Diabetes, Digestive, and Kidney Diseases Extramural Research, with its first action in the period on May 26, 2021. That counts only the money obligated in fiscal 2021 to 2025.
Which federal programs fund Mitotherapeutix, LLC?
Its largest are Diabetes, Digestive, and Kidney Diseases Extramural Research and Alcohol Research Programs.
Other grant recipients in Woodbridge
Largest federal grant recipients in Connecticut · Federal grants in Connecticut